News and Trends 3 May 2016
Llama Antibody Inhalation gets Positive Results for Respiratory Virus
Ablynx has gotten positive results for its candidate (ALX-0171) in Phase I/IIa trial for infants infected with a life-threatening virus - respiratory…
Ablynx
- Latest Posts
News and Trends 29 Feb 2016
Our Top 5 Articles on Biotech & Rare Disease
Today is Rare Disease Day 2016. Because it is an important field for Biotech, we went back to review some…
News and Trends 16 Feb 2016
World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies
Ablynx, the llama antibody biotech in Belgium, has now proven to be on solid ground regarding their orphan drug for a…
News and Trends 3 Feb 2016
When the Llama met the Lion: Antibodies Unlock Milestone Payment for Skin Disease
ArGEN-X in Ghent (Belgium) combines the diversity of the llama immune system with a clinical antibody pipeline which Leo Pharma (Denmark), is…
ADVERTISEMENT
News and Trends 26 Nov 2015
Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck
Ablynx – the Belgian Nanobody biotech (which uses monoclonal antibodies of Alpacas) has entered a new and exclusive partnership with…
News and Trends 15 Oct 2015
Ablynx richly rewarded for MSD’s Nanobody Proof in Immuno-Oncology
Ablynx - the Belgian nanobody biotech (which uses monoclonal antibodies of Alpacas), has now achieved it's first pre-clinical milestone in…
News and Trends 1 Oct 2015
Asceneuron’s latest stab at the Alzheimer’s challenge with Sofinnova
Paris based Sofinnova continues to invest in the Alzheimer's fight, with a €27.5M pot given to Swiss Asceneuron (originally a…
News and Trends 27 Jul 2015
Ablynx and MSD upgrade their €1.7Bn deal to gigantic €5.7Bn
Using camel antibodies as drugs, sounds crazy? Belgian Ablynx is exactly doing that and has been very successful so far. It's…
News and Trends 28 May 2015
Biotechs outperformed in the top 40 European Tech Companies
EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs (Small and Medium-size companies), announced the launch…
News and Trends 22 May 2015
Genzyme joins the never-ending list of Ablynx’ partners
Genzyme is joining Ablynx' partner list, which already includes AbbVie, Boehringer Ingelheim, Eddingpharm, Merck & Co, Merck Serono and Novartis.…
News and Trends 15 May 2015
Ablynx gets tangled up in partnerships with Big Pharma companies
The Belgium-based company is leading more than 20 pre-clinical and clinical programmes with several partners to put the Nanobody technology…
News and Trends 19 Aug 2014
Ablynx gain €2.1m to develop a novel Nanobodies for Ocular applications
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies, a novel class of therapeutic proteins based…
